Sign In
Buy JAZZ
$230.93
+4.81 (+2.13%)
At Close: Jun 03, 2026
Jazz Pharmaceuticals plc (JAZZ) CEO Bruce Cozadd on Q4 2020 Results - Earnings Call Transcript
08:48pm, Tuesday, 23'rd Feb 2021
Jazz Pharmaceuticals plc (JAZZ) CEO Bruce Cozadd on Q4 2020 Results - Earnings Call Transcript
Recap: Jazz Pharmaceuticals Q4 Earnings
04:24pm, Tuesday, 23'rd Feb 2021
Shares of Jazz Pharmaceuticals (NASDAQ:JAZZ) were flat in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share decreased 9.50% year over year to $4.00, whic
8 Medical Marijuana Stocks That Are Just What the Doctor Ordered
11:46am, Tuesday, 23'rd Feb 2021
With many people seeking natural therapies to address pandemic-related stress, the backdrop is favorable for marijuana stocks. The post 8 Medical Marijuana Stocks That Are Just What the Doctor Ordered
Drug/Biotech Stock Q4 Earnings on Feb 23: JAZZ, ARNA & More
09:06am, Monday, 22'nd Feb 2021
Let us take a look at five small biotech companies, JAZZ, ARNA, HALO, EPZM, ESPR, which are gearing up for their earnings release.
Jefferies Top Growth Stocks to Buy Include 2 Red-Hot Sports Betting Winners
07:54am, Monday, 22'nd Feb 2021
Increasingly, the Wall Street firms we cover are starting to agree that, while the future is still bright for the U.S.
Should You Invest in Marijuana Stocks & ETFs Now?
05:25pm, Thursday, 18'th Feb 2021
CNBC's cannabis expert Tim Seymour discusses the outlook for the industry.
Nextleaf Solutions expects its patent-rich portfolio to pay off as Jazz Pharmaceuticals acquires GW Pharmaceuticals
01:32pm, Wednesday, 17'th Feb 2021
Jazz Pharmaceuticals PLC's (NASDAQ:JAZZ) recently-announced deal to acquire cannabis-derived drug maker GW Pharmaceuticals plc (NASDAQ:GWPH) for US$7.2 billion in cash and stock has boosted investor
Cannabinoid Capital (Podcast Transcript)
02:22am, Tuesday, 16'th Feb 2021
Cannabinoid Capital (Podcast Transcript)
Will There Be More M&A for the Cannabis Industry in 2021?
06:55am, Friday, 12'th Feb 2021
The sector is hot again on the heels of two large deals.
Cannabis Stocks Rise on Hopes of Federal Legalization in US
11:41am, Wednesday, 10'th Feb 2021
Cannabis stocks seem poised to gain on hopes of removal of the federal ban on cannabis products under the new administration.
Cannabinoid Capital (Podcast)
09:00am, Wednesday, 10'th Feb 2021
Cannabinoid Capital (Podcast)
Cardiol CEO sees bright future for pharmaceutically produced cannabidiol after blockbuster Jazz-GW Pharmaceutical deal
02:54pm, Sunday, 07'th Feb 2021
A blockbuster deal announced earlier this week could be a sign of a bright future for cannabidiol-oriented pharmaceutical companies. On Wednesday, cancer therapy developer Jazz Pharmaceuticals PLC (NA
Willow Biosciences is set to benefit from Jazz Pharmaceuticals acquisition of GW Pharmaceuticals
02:54pm, Sunday, 07'th Feb 2021
Jazz Pharmaceuticals PLC's (NASDAQ:JAZZ) recently-announced deal to acquire cannabis-derived drug maker GW Pharmaceuticals plc (NASDAQ:GWPH) for US$7.2 billion in cash and stock has boosted investor
4 Green Flags For Jazz Pharmaceuticals' Buyout of GW Pharmaceuticals
06:30am, Saturday, 06'th Feb 2021
Jazz is paying $7.2 million to buy the maker of CBD-derived drug Epidiolex. Is it a smart deal?
Cannabis Stocks Fly High On Biden Administration Potential
12:26pm, Friday, 05'th Feb 2021
Welcome back to our weekly series, Sc haeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry will d
